C57BL/6JCya-Prrx2em1/Cya
Common Name
Prrx2-KO
Product ID
S-KO-18674
Backgroud
C57BL/6JCya
Strain ID
KOCMP-20204-Prrx2-B6J-VA
When using this mouse strain in a publication, please cite “Prrx2-KO Mouse (Catalog S-KO-18674) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Prrx2-KO
Strain ID
KOCMP-20204-Prrx2-B6J-VA
Gene Name
Product ID
S-KO-18674
Gene Alias
Prx2, S8
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 2
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000041659
NCBI RefSeq
NM_009116
Target Region
Exon 2
Size of Effective Region
~1.3 kb
Overview of Gene Research
Prrx2, the paired-related homeobox transcription factor, has been implicated in multiple biological processes. It participates in regulating gene expression and is associated with pathways like Wnt/β -catenin, TGF -β, and Hippo. Prrx2 is important in cell differentiation, proliferation, and in processes related to various diseases, making genetic models valuable for studying its functions [2,3,4,6,8,9].
Silencing Prrx2 in breast cancer cells inhibited their proliferation and growth in vitro and in vivo, and also down-regulated the Wnt/β -catenin signaling pathway, suggesting its oncogenic role in breast cancer [8]. In colon cancer, inhibition of Prrx2 reduced the invasive and migrating abilities of cells, hindered epithelial-mesenchymal transition (EMT), and suppressed liver metastasis through inactivation of the Wnt/β -catenin pathway [6]. Myoblast-derived exosomal Prrx2 enhanced osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) by transcriptionally regulating lncRNA-MIR22HG to activate the Hippo pathway, alleviating osteoporosis in mice [2]. In glioblastoma, circLRFN5 binds to Prrx2 protein and promotes its degradation, suppressing glioblastoma progression as Prrx2 transcriptionally upregulates GCH1, a ferroptosis suppressor [1]. In prostate cancer, activation of Prrx2 promoted enzalutamide resistance, and its expression was highest in double-negative prostate cancer, correlating with reduced overall survival [3]. In lung adenocarcinoma, Prrx2 was highly expressed, acting as a positive regulator of cell proliferation and a negative regulator of apoptosis by binding to the PSMD1 promoter [4]. Silencing Marveld3 upregulated Prrx2, which attenuated radiation-induced lipid peroxidation in skin cells, potentially protecting against radiation-induced ferroptosis [5]. In neuropathic pain, a spinal-specific super enhancer regulated chronic constriction injury-induced neuropathic pain by driving Prrx2 transcription in dorsal horn neurons, and knocking down Prrx2 alleviated neuropathic pain behaviors [7]. In odontoblast differentiation, Prrx2 may regulate pannexin 3 expression [10].
In conclusion, Prrx2 is involved in diverse biological functions such as cell proliferation, differentiation, and apoptosis. Through model-based research, its role in diseases like cancer, osteoporosis, radiation-induced skin injury, and neuropathic pain has been revealed. These findings provide insights into potential therapeutic targets for these diseases.
References:
1. Jiang, Yang, Zhao, Junshuang, Li, Rongqing, Gao, Liang, Cui, Daming. 2022. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. In Journal of experimental & clinical cancer research : CR, 41, 307. doi:10.1186/s13046-022-02518-8. https://pubmed.ncbi.nlm.nih.gov/36266731/
2. Li, Yunchao, Wang, Xiaoxiao, Pan, Changyu, Chen, Zejun, He, Haoyu. 2023. Myoblast-derived exosomal Prrx2 attenuates osteoporosis via transcriptional regulation of lncRNA-MIR22HG to activate Hippo pathway. In Molecular medicine (Cambridge, Mass.), 29, 54. doi:10.1186/s10020-023-00649-y. https://pubmed.ncbi.nlm.nih.gov/37081396/
3. Rodríguez, Yara, Unno, Kenji, Truica, Mihai I, Han, Huiying, Abdulkadir, Sarki A. . A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer. In Cancer research, 82, 2110-2123. doi:10.1158/0008-5472.CAN-21-3565. https://pubmed.ncbi.nlm.nih.gov/35405009/
4. Liu, Lihua, Liu, Aihua, Liu, Xuezheng. 2022. PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1. In Translational oncology, 27, 101586. doi:10.1016/j.tranon.2022.101586. https://pubmed.ncbi.nlm.nih.gov/36379103/
5. Cao, Jinming, Wu, Mengyao, Mo, Wei, Zhang, Bin, Cao, Jianping. 2024. Upregulation of PRRX2 by silencing Marveld3 as a protective mechanism against radiation-induced ferroptosis in skin cells. In Molecular medicine (Cambridge, Mass.), 30, 182. doi:10.1186/s10020-024-00958-w. https://pubmed.ncbi.nlm.nih.gov/39434056/
6. Chai, Wen-Xiao, Sun, Li-Guo, Dai, Fu-Hong, Zheng, Ning-Gang, Cai, Hong-Yi. 2019. Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway. In Pathology, research and practice, 215, 152593. doi:10.1016/j.prp.2019.152593. https://pubmed.ncbi.nlm.nih.gov/31471104/
7. Tao, Yang, Wang, Qi-Hui, Li, Xiao-Tong, Cao, Jun-Li, Pan, Zhiqiang. 2023. Spinal-Specific Super Enhancer in Neuropathic Pain. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 43, 8547-8561. doi:10.1523/JNEUROSCI.1006-23.2023. https://pubmed.ncbi.nlm.nih.gov/37802656/
8. Lü, Z D, Yang, Z C, Jin, L Y, Kong, B, Wang, H B. . [Effects of Prrx2 gene silencing on the proliferation of breast cancer and its molecular mechanisms]. In Zhonghua yi xue za zhi, 100, 942-946. doi:10.3760/cma.j.cn112137-20190710-01309. https://pubmed.ncbi.nlm.nih.gov/32234171/
9. Juang, Yu-Lin, Jeng, Yung-Ming, Chen, Chi-Long, Lien, Huang-Chun. 2016. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer. In Molecular carcinogenesis, 55, 2247-2259. doi:10.1002/mc.22465. https://pubmed.ncbi.nlm.nih.gov/26824226/
10. Tanaka, Manami, Sugimoto, Asuna, Iwata, Kokoro, Oishi, Atsushi, Iwamoto, Tsutomu. 2024. Prrx2, the paired-related homeobox transcription factor, functions as a potential regulator of pannexin 3 expression in odontoblast differentiation. In Journal of oral biosciences, 67, 100601. doi:10.1016/j.job.2024.100601. https://pubmed.ncbi.nlm.nih.gov/39733924/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
